Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2023.1251817 Cardiovascular Medicine Systematic Review Hypertension among adolescents in sub-Saharan Africa: a systematic review NsanyaMussa K. 1 * AbramsonRachel 2 KisigoGodfrey A. 1 3 HicknerAndy 2 NyanzaElias C. 4 PeckRobert N. 1 2 4 KapigaSaidi H. 1 3 Mwanza Intervention Trials Unit/National Institute for Medical Research, Mwanza, Tanzania Weill Cornell Medicine – Cornell University, New York, NY, United States Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom Catholic University of Health and Allied Sciences, School of Public Health, Mwanza, Tanzania

Edited by: Okechukwu Ogah, University of Ibadan, Nigeria

Reviewed by: Bert-Jan Van Den Born, Amsterdam University Medical Center, Netherlands

Maria Grazia Modena, University of Modena and Reggio Emilia, Italy

Paolo Alberto Gasparini, University Hospital of Modena, Italy, in collaboration with reviewer [MGM]

 Correspondence: Mussa K. Nsanya mussa.nsanya@mitu.or.tz 07122023 2023 101251817 02072023 18102023 © 2023 Nsanya, Abramson, Kisigo, Hickner, Nyanza, Peck and Kapiga. 2023Nsanya, Abramson, Kisigo, Hickner, Nyanza, Peck and Kapiga

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 Introduction

Hypertension (HTN) among adolescents is common in high-income countries, and leads to increased premature cardiovascular diseases (CVD). In sub-Saharan Africa (SSA), the prevalence of HTN among adolescents, associated risk factors and CVD complications are not well-described. Such data is needed for planning public health programs to prevent premature CVD in SSA.

Methods

We systematically searched 5 databases (MEDLINE, Embase, Google Scholar, Web of Science, and African Index Medicus) from their establishment to December 2021. Key search terms were: adolescent, arterial hypertension, and names of the 48 countries in SSA. We used Covidence® to manage the search results. The review was registered in the Open Science Framework (OSF) https://osf.io/p5sbt/.

Results

We identified 4,008 articles out of which we screened 3,088 abstracts, and reviewed 583 full-text articles. We finally included 92 articles that were published between 1968 to December 2021. The majority were cross-sectional studies (80%) and conducted in school settings (78%). The risk of bias was low for 59 studies (64.1%), moderate for 29 studies (31.5%), and high for 4 studies (4.3%). Overall, the prevalence of HTN varied widely from 0.18% to 34.0% with a median (IQR) of 5.5% (3.1%, 11.1%). It was relatively higher in studies using automated blood pressure (BP) devices, and in studies defining HTN using thresholds based on percentile BP distribution for one's height, age, and sex. In addition, the prevalence of HTN was significantly higher in studies from Southern Africa region of SSA and positively correlated with the year of publication. Across studies, traditional risk factors such as age, sex, body mass index, and physical inactivity, were commonly found to be associated with HTN. In contrast, non-traditional risk factors related to poverty and tropical diseases were rarely assessed. Only three studies investigated the CVD complications related to HTN in the study population.

Conclusion

The prevalence of HTN among adolescents in SSA is high indicating that this is a major health problem. Data on non-traditional risk factors and complications are scarce. Longitudinal studies are needed to clearly define the rates, causes, and complications of HTN.

Systematic Review Registration

https://osf.io/p5sbt/, identifier (10.17605/OSF.IO/P5SBT).

 hypertension blood pressure risk factors adolescents sub-Saharan Africa cardiovascular complications section-at-acceptanceCardiovascular Epidemiology and Prevention Introduction

Hypertension (HTN) among adolescents is common globally, but most data come from high-income countries (1). Much less information is available from sub–Saharan Africa (SSA) where adolescents constitute about 18% of the population (2). In high-income countries, obesity is the major risk factor for HTN, and other traditional risk factors such as physical inactivity, unhealthy diet, and family history of HTN are also common (3, 4). In SSA, potential risk factors related to poverty and tropical diseases, also referred to as “non-traditional” risk factors, may be common. They include low birth weight, malnutrition, stunted growth, malaria, and/or other tropical infectious diseases. However, there is limited information describing the contribution of non-traditional risk factors for HTN among adolescents in Africa (3, 5–9).

Increasing evidence from long-term follow-up studies in high-income countries shows that HTN during adolescence is strongly associated with premature onset of cardiovascular diseases (CVD) including left ventricular hypertrophy, chronic kidney disease, decline in cognitive function, and type-2-diabetes mellitus (10–13). By comparison, little is known about blood pressure (BP) trajectory and its potential complications among adolescents in SSA (14, 15).

We are aware of three systematic reviews (and meta-analyses) describing the burden of HTN in children and adolescents in Africa (16–18). The reviews used published data from 1996 to 2017 and from 2017 to 2020, and from 2010 to 2021with the pooled estimates for prevalence of HTN of 5.5% and 7.5% and 9.9% respectively. The major limitations of two of these reviews were that they combined BP measurements for adolescents with those of children as young as 2 years. Also, neither of the reviews reported non-traditional risk factors and complications of HTN. Since the epidemiology of HTN varies between adolescents and children, studies that focus on adolescents only may provide useful information specific for this population.

Therefore, the current systematic review aims to describe the burden, risk factors, and complications of HTN among adolescents aged 10–19 years in SSA. Findings from this study will inform (1) programs promoting regular and proper BP measurements among adolescents; (2) primary CVD preventive interventions targeting adolescents; and (3) the design of new studies aimed to bridge existing gaps in the literature.

 Methods Databases and search strategy

We systematically searched for studies on HTN among adolescents aged 10–19 years in SSA, published in any language, from a range of databases from their inception until December 2021. Two investigators (MKN and RHA) were supported by a librarian (AH) to develop and conduct the search strategy. We searched MEDLINE, Embase, and African Index Medicus to identify relevant published literature. We searched Embase and Web of Science Core collection to identify studies that had been presented as conference abstracts but not yet published as full-length journal articles. We searched Google Scholar to identify potentially relevant information apart from the published research articles (19). The search strategy consisted of three concepts, combined with Boolean operators: adolescents, sub-Saharan Africa (names of the 48 countries in SSA), and hypertension. Both controlled vocabulary and free-text keywords were identified using the Yale MeSH Analyzer (20). Proximity operators were incorporated to retrieve variations of phrases. No limits were used for any of the databases. Terms used for HTN were “arterial hypertension”, “hypertension” and “blood pressure”. Terms for adolescent were “adolescent”, “teen”, and “youth”. The specific search strategies used for each of the databases are attached in Supplementary Appendix 1.

 Selection criteria

Using Covidence (Melbourne, VIC 3000, Australia), two investigators (MKN and RHA) independently assessed the articles for eligibility in two steps. First, they independently screened the titles and abstracts of the retrieved articles. Then, they obtained full texts of potentially eligible articles and independently reviewed them for possible inclusion. A third reviewer (GAK) resolved any disagreements between the two investigators. Throughout this selection process, duplicates were removed both by Covidence and the two reviewers. We used Google Translate for studies published in languages other than English.

We included studies if they were: observational (cross-sectional, case-control, and cohort studies) or experimental studies, enrolled adolescents residing in SSA, reported at least one of the outcomes of interest (incidence/prevalence, risk factors, and complications of HTN), and reported data for a group or subgroup of participants within the ages of 10–19 years.

We excluded studies if they were animal studies, only reported non-systemic HTN (e.g., portal hypertension, pulmonary hypertension, and intracranial hypertension), case studies, case series, studies with sample size less than 5, qualitative studies and systematic reviews, studies including only participants with high BP, studies including only adolescents from a single high-risk group (e.g., those with HIV, sickle cell disease, malnutrition), and studies including adolescents with secondary HTN.

 Data extraction procedures

The two investigators (MKN and RHA) independently extracted data using a pre-validated data extraction table. This process did not use any automation tools. Extracted data included: the author's name, year of publication, country of study, study design, participant's age range, average age, sample size, type of BP measurement device used (automated vs. manual), criteria used for defining HTN, prevalence and/or incidence estimates, risk factors and complication of HTN. We only extracted data for the eligible age range. We hand-calculated proportion of adolescents with HTN in the eligible age range if this information was not reported and where the numerator and the corresponding denominator were available. For cohort studies, we used prevalence estimates from baseline data and incidence from follow-up visits. We left blank any information which was either missing or not reported for the eligible age range. A third reviewer (GAK) resolved any discrepancies in the extracted data.

 Evaluation of risk of bias

The two investigators (MKN and RHA) independently assessed each of the included studies for risk of bias using the Newcastle-Ottawa Scale (NOS) for assessment of the quality of non-randomized studies (21). The assessment was done on three domains: (1) selection of study participants, (2) comparability of participants in different outcome groups, and (3) ascertainment of study outcomes or exposure status. Across the three domains, a range of “high-quality” items could score a star (depending on the study design). Case-control and cohort studies have a total of 8 items with a maximum score of 9 stars. And cross-sectional studies have a total of 7 items with a maximum score of 10 stars. Studies with a total score of ≥7 stars were regarded as of high quality, 4–6 stars as of moderate quality, and 0–3 stars as of low quality (high risk of bias). We resolved any disagreements on the assessment of the risk of bias by consensus.

 Data synthesis and analysis

We summarized the study selection process using a PRISMA flow diagram (22). We used tables to show characteristics of included studies, prevalence and/or incidence of HTN, and associated risk factors. We summarized our findings using proportions (for categorical data), and mean and/or median (for continuous data). We assessed the association between prevalence of HTN and each of the following study characteristics: year of publication, study settings (rural, rural/urban and urban), sub Saharan Africa region from which the studies came from (West, South, East, and Central), type of BP measurement device used (manual vs. automated), and criteria for defining HTN (cut offs based on a fixed vs. percentile BP values). We used meta-regression analysis to assess the adjusted association between prevalence of HTN and all the five study characteristics mentioned above. We did not perform pooled analysis due to heterogeneity in methods as well settings/context across the studies.

Ethical considerations

This study was exempted from ethical approval as it involved a review of published data. To our knowledge, all included studies obtained ethics clearance before data collection. The protocol for this review was registered in the Open Science Framework (OSF) https://osf.io/p5sbt/.

 Role of funding organization

The funders had no role in the study design, data collection, data analysis, data interpretation, and writing of this manuscript.

 Results

We identified 4,008 articles, and after removing 920 duplicates, we screened the title and abstract of the remaining 3,088 articles and selected 583 articles for full-text review. We could not retrieve the full texts of 15 publications (Supplementary Appendix 2). Of the remaining 568 articles, 476 were excluded after a full-text review (their exclusion reasons are summarized in the Figure 1 PRISMA flow diagram below. We finally included 92 articles in our systematic review.

PRISMA flow diagram showing the study selection process.

 Characteristics of the included studies

Table 1 shows the characteristics of the 92 included studies. The studies were published from 1968 to 2021, with the majority (75%) published between 2010 and 2021. The studies came from 14 (29%) out of the 48 countries in SSA. The majority of the studies came from the west (46.2%), followed by the south (29.7%), east (22.0%), and central (2.2%) African regions. Of the 92 studies, the majority were cross-sectional (80.0%), and conducted in schools (70.3%) and in urban settings (65.9%). They included a total of 89,599 subjects with sample sizes ranging from 53 to 7,746 (median = 670, IQR: 375, 1,080). The risk of bias was low for 59 studies (64.1%), moderate for 29 studies (31.5%), and high for 4 studies (4.3%).

Characteristics of studies with data on hypertension among adolescents aged 10–19 years in sub-Saharan Africa (N = 92).

Author Year of publication Country Study design Age range Average age Sample size Female (%) Setting Urban/Rural
Akinkugbe OO (23) 1968 Nigeria Cross-sectional 10–19 1,119 48.8 Community Rural
Johnson TO (24) 1971 Nigeria Cross-sectional 10–19 370 59.5 Community Urban
Akinkugbe A (25) 1976 Nigeria Cross-sectional 15–19 103 100 Community Rural
Ayobanji Ayoola E (26) 1979 Nigeria Cross-sectional 11–19 487 39.6 School Urban
Abu-Bakare A (27) 1983 Nigeria Cross-sectional 11–18 14.3 684 100 School Urban
Idahosa PE (28) 1985 Nigeria Cross-sectional 15–19 109 0 Community Urban
Eferakeya AE (29) 1986 Nigeria Cross-sectional 10–15 12.5 679 45.5 School Urban & Rural
Adams-Campbell LL (30) 1987 Nigeria Cross-sectional 12–17 118 34.8 School Urban
Kitange HM (31) 1993 Tanzania Cross-sectional 15–19 16.8 1,673 55.2 Community Urban & Rural
Muraguri PW (32) 1997 Kenya Cross-sectional 13–18 403 49.4 School Urban
Kane A (33) 1998 Senegal Cross-sectional 12–19 132 Community Rural
Longo-Mbenza B (34) 1999 Zaire Cross-sectional 13–16 471 33.1 School Urban & Semi-Urban
Schutte AE (#167) (35) 2003 South Africa Cross-sectional 10–19 631 53.1 School Urban & Rural
Schutte AE (#168) (36) 2003 South Africa Cross-sectional 10–15 695 53.8 School Urban & Rural
Schutte AE (#1885) (35) 2003 South Africa Cross-sectional 10–15 631 53.1 School Urban & Rural
VanRooyen JM (37) 2005 South Africa Cross-sectional 10–15 12.4 775 53.1 School Urban & Rural
Chiolero A (38) 2007 Seychelles Cross-sectional 12–15 7,746 51.4 School
Thurston SW (39) 2007 Seychelles Cohort 12–15 524 53.4 Community Urban
Mijinyawa MS (39) 2008 Nigeria Cross-sectional 13–19 15.9 968 50.8 School Urban
Monyeki KD (40) 2008 South Africa Cross-sectional 10–13 1,307 49.3 School Rural
Cournil A (41) 2009 Senegal Cohort 16–19 17.9 1,288 46.4 Community
Mijinyawa MS (42) 2009 Nigeria Cross-sectional 13–18 15.6 718 56.9 School Urban
Odey F (43) 2009 Nigeria Cross-sectional 10–18 14.6 375 61 School Urban
Ansa VO (44, 45) 2010 Nigeria Cross-sectional 10–17 13.4 964 51 School Urban
Ejike C (45) 2010 Nigeria Cross-sectional 13–18 15.2 843 47.3 School Urban & Semi-Urban
Kruger HS (46) 2010 South Africa Cross-sectional 13–18 15.6 178 60.9 School
Chiolero A (47) 2011 Seychelles Cohort 12–15 12.5 3,461 51.8 School
Hawkesworth S (48) 2011 Gambia Interventional: randomized trial 11–17 14.1 1,267 48.2 Community Rural
Mamabolo RL (49) 2011 South Africa Cross-sectional 12–19 307 56.7 School
Meehan KA (50) 2011 Sierra Leone Cross-sectional 15–16 407 Hospital Urban
Bukabau JB (51) 2012 DRC/Zaire Cross-sectional 15–20 18.7 524 49.8 School Urban
Griffiths PL (52) 2012 South Africa Cohort 16 16 358 47 Community Urban
Okoh BA (53) 2012 Nigeria Cross-sectional 10–12 483 56.7 School Urban
Okpere AN (54) 2012 Nigeria Cross-sectional 10–19 13.6 615 51.4 School Urban
Oyewole OO (55) 2012 Nigeria Cross-sectional 12–18 14.9 1638 51.7 School Urban
Goon D (56) 2013 South Africa Cross-sectional 10–13 140 45.7 School Rural
Lyngdoh T (57) 2013 Seychelles Cohort 12–15 407 54.1 School Urban
Okpere AN (58) 2013 Nigeria Cross-sectional 10–19 820 49.9 School Urban
Ujunwa FA (59) 2013 Nigeria Cross-sectional 10–18 15 2,694 52 School Urban
Mushengezi B (60) 2014 Tanzania Cross-sectional 12–19 16.5 582 47.9 School Urban
Okagua J (61) 2014 Nigeria Cross-sectional 10–18 14.5 1,080 49 School Urban
Kagura J (14) 2015 South Africa Cohort 18 18 1,587 51.7 Community Urban
Nkeh-Chungag B (62) 2015 South Africa Cross-sectional 13–17 15.1 392 69.9 School Semi-Urban
Odunaiya NA (63) 2015 Nigeria Cross-sectional 15–18 16.4 1,079 53.5 School Rural
Oyeyemi AY (64) 2015 Nigeria Cross-sectional 13–18 15.6 1,048 37.7 School Urban
Ratovoson R (65) 2015 Madagascar Cross-sectional 15–17 638 Community Urban & Rural
Awotidebe A (66) 2016 South Africa Cross-sectional 13–14 13.9 310 61.9 School
Munthali RJ (67) 2016 South Africa Cohort 1,589 51.7 Community Urban
Strassman BI (68) 2016 Mali Cohort
Uwaezuoke SN (69) 2016 Nigeria Cross-sectional 10–19 14.8 2,419 48.7 School Urban
Alicke M (70) 2017 Ghana Cross-sectional 14–15 15.2 188 50 Hospital Rural
Bedu-Addo G (6) 2017 Ghana Cohort 14–15 14.8 155 47 Community Rural
Etyang AO (71) 2017 Kenya Cross-sectional 11–17 13.3 686 55.7 Community Urban
Etyang AO (72) 2018 Kenya Cross-sectional 11–17 13.3 609 55.5 Community Urban
Ezeudu CE (73) 2018 Nigeria Cross-sectional 10–19 14.6 984 52.2 School Rural
Hendry LM (74) 2018 South Africa Cohort 17.9 1,947 73.3 Community Urban
Isezuo KO (75) 2018 Nigeria Cross-sectional 10–18 14.5 800 47 School Urban
Leyvraz M (76) 2018 Seychelles Cohort 12–15 15.6 5,967 51.4 School Urban & Rural
Masocha V (77) 2018 South Africa Cohort 14 14.9 289 59.9 School Urban
Nakiriba R (78) 2018 Uganda Cross-sectional 12–18 15.4 688 100 School Urban
Omisore AG (79) 2018 Nigeria Cross-sectional 10–19 13.7 1,000 49 School Urban & Rural
Abu OO (#201) (80) 2019 Nigeria Cross-sectional 10–19 14 420 57.4 School Urban
Adeomi AA (81) 2019 Nigeria Cross-sectional 10–19 14.4 313 58.5 School Urban
Amponsem-Boateng C (82) 2019 Ghana Cross-sectional 15–17 571 61.2 School
Chungag A (83) 2019 South Africa Cross-sectional 10–14 11.9 540 53.7 School
Frigati L (84) 2019 South Africa Case-control 9–14 12 620 49.8 Community Urban
Lule SA (#101) (85) 2019 Uganda Cohort 10–11 10.2 1,119 47.9 Community Urban & Rural
Lule SA (#3098) (86) 2019 Uganda Cohort 10–11 10.4 815 49 Community Urban & Rural
Lule SA (#409) (87) 2019 Uganda Cohort 10–11 10.2 1,119 47.9 Community Urban & Rural
Nkwana MR (88) 2019 South Africa Cross-sectional 11–15 591 46.7 School Urban
Nsanya MK (89) 2019 Tanzania, Uganda Cross-sectional 12–15 827 50.4 School Urban
Abiodun O (90) 2019 Nigeria Cross-sectional 15–19 16.51 6,980 56.2 School
Azupogo F (91) 2020 Ghana Cross-sectional 15–19 16.9 1,727 49.6 Community Urban & Rural
Katamba G (92) 2020 Uganda Cross-sectional 12–19 15.6 616 65.6 School Urban
Masocha V (93) 2020 South Africa Cohort 14–16 14.9 186 56.5 School Urban
Mokgwathi M (94) 2020 Botswana Cross-sectional 17.1 252 68.3 School Urban & Rural
Raphadu TT (95) 2020 South Africa Cross-sectional 13–19 218 55.5 School Urban & Rural
Sungwa EE (96) 2020 Tanzania Cross-sectional 10–16 350 School Urban
Ugochukwu EF (97) 2020 Nigeria Cross-sectional 10–17 593 51.2 School Urban
Ukoh U (98) 2020 Nigeria Cross-sectional 10–19 15.1 2,401 50.2 School Urban
Akinbodewa AA (99) 2021 Nigeria Cross-sectional 10–17 12.9 53 52.8 Community Rural
Ayogu RN (100) 2021 Nigeria Cross-sectional 10–19 401 53.1 Community Rural
Chungag A (101) 2021 South Africa Cohort 10–14 411 54.3 School Urban & Rural
DuPlessis JP (102) 2021 South Africa Cross-sectional 13–14 15.2 172 61 School Urban
Engwa G (103) 2021 South Africa Cross-sectional 13–16 234 School Rural
Letswalo BP (104) 2021 South Africa Cross-sectional 13–16 14.1 232 78.4 School Rural
Lwabukuna WC (105) 2021 Tanzania Cross-sectional 14–19 16.9 217 68 School Urban
Meer R (106) 2021 South Africa Cohort 5–18 1,891 51.7 Community Urban
Nganou-Gnindjio CN (107) 2021 Cameroon Cross-sectional 12–19 1,392 School Urban & Semi-Urban
Nsanya MK (4) 2021 Tanzania Cross-sectional 11–15 13.9 500 56.6 School Urban
Sekokotla AM (108) 2021 South Africa Case-control 13–17 76 100 School Urban
Shokunbi OS (109) 2021 Nigeria Cross-sectional 10–19 488 64.3 School Urban
Methods of BP measurements

The studies used different devices for BP measurements, and the definition of HTN was not consistent across studies (Table 2).

Studies that reported prevalence and incidence of hypertension among adolescents aged 10–19 years in sub-Saharan Africa (N = 78).

Author Year of publication Device for BP meas. Days for BP meas. Number of BP meas. Calculation of final BP meas. HTN definition or guideline Pre-HTN (%) HTN (%) Elevated BP (%) Incidence Mean SBP (SD) Mean DBP (SD)
Akinkugbe OO (23) 1968 Mercury 1 1 WHO, BP ≥ 140/90 2.8 106.4 65.6
Johnson TO (24) 1971 Mercury 1 1 WHO, BP ≥ 160/95 0.8 117.9 74.6
Ayobanji Ayoola E (26) 1979 Mercury 1 3 Average BP >  + 2 SD 3.3 106.5 (11.8) 61 (9)
Abu-Bakare A (27) 1983 WHO, BP ≥ 133/90 6.8 110.6 (11.1) 69.5 (10.5)
Idahosa PE (28) 1985 Automated 1 2 Average WHO, BP ≥ 160/95 11.9 1.8 122 (15.7) 63 (11.1)
Eferakeya AE (29) 1986 Finapres 1 Continuous 5 min Average BP >  + 2 SDs 4.47
Adams-Campbell LL (30) 1987 Mercury 1 3 Average of 2nd & 3rd WHO, BP ≥ 140/90 2.3
Kitange HM (31) 1993 Mercury 1 2 Average WHO, BP ≥ 160/95 0.4 114.1 (12.4) 66.1 (9.5)
Muraguri PW (32) 1997 Mercury 1 3 Average Second Report 1 109.5 (9.9) 66.5 (6.5)
Kane A (33) 1998 Aneroid 1 1 Third Report 1.5 108.9 (12.2) 64.3 (10.1)
Schutte AE (35) (#167) 2003 Finapres 1 Continous Average Third Report 20.7
Schutte AE (36) (#168) 2003 Finapres 1 Continous Average Third Report 17.3 20.8
Schutte AE (35) (#1885) 2003 Finapres 1 Continous Average Third Report 15.5 18.4
Chiolero A (38) 2007 Automated 1 2 Average Fourth Report 110.5 (12) 67.2 (8.5)
Monyeki KD (40) 2008 Automated 1 3 Average Fourth Report 4.9
Cournil A (41) 2009 Mercury 1 3 WHO, BP ≥ 140/90 12.2 120.5 (12.8) 72.5 (12.4)
Mijinyawa MS (42) 2009 Mercury 1 3 Average Third Report 4.5 111 (13.8) 73 (9.5)
Odey F (43) 2009 Mercury 1 3 Average Fourth Report 7.5 6.7 114.6 (12.6) 62.9 (8.7)
Ansa VO (44) 2010 Mercury 1 2 Average Fourth Report 1.8
Ejike C (45) 2010 Mercury 1 2 2nd reading BP > mean + 2SD 23.4 10.1
Kruger HS (46) 2010 Mercury 1 2 Average Fourth Report 26.4
Chiolero A (47) 2011 Automated 1 2 Average Fourth Report 7.3 109.8 (11.4) 66.8 (8.2)
Hawkesworth S (74) 2011 Automated 1 3 Third Report 5.46 110.5 (9.0) 64.7 (7.6)
Meehan KA (50) 2011 Mercury 1 1 WHO-ISH 1999, JNC7 1.2 104.2 (12.3) 64.3 (8.4)
Bukabau JB (51) 2012 Aneroid 1 3 Average WHO, BP ≥ 140/90 3.1 107.3 (11.3) 70.9 (8.1)
Griffiths PL (52) 2012 Automated 1 3 Average of 2nd & 3rd Fourth Report 11.2 1.9 114.8 (10.4)
Okoh BA (53) 2012 Mercury 1 3 Average Fourth Report 3.9
Okpere AN (54) 2012 Mercury 1 3 Average Second Report 2.8
Oyewole OO (55) 2012 Aneroid 1 1 Fourth Report & JNC7 1.5 0.18 81.4 (14.3) 48.5 (9.4)
Goon D (56) 2013 Automated 1 Fourth Report 0.6 99.4 (9.4) 54.8 (5.7)
Okpere AN (58) 2013 Mercury 1 3 Average Fourth Report 3.2 114.2 (9.3) 70.4 (7.8)
Ujunwa FA (59) 2013 Mercury 3 3 Average Fourth Report 13.5 12 108.31 (11.8) 71.2 (7.9)
Mushengezi B (60) 2014 Automated 1 2 Average Fourth Report & WHO 4.0 120 (11) 69 (8)
Okagua J (61) 2014 Mercury 1 3 Average Fourth Report 4.3 111.1 (14.7) 66.3 (11.7)
Kagura J (14) 2015 Automated 1 3 Average of 2nd & 3rd Fourth Report 12.2 15.7 117.9 (11.0) 71.0 (9.0)
Nkeh-Chungag B (62) 2015 Automated 1 3 Average Fourth Report 12.3 21.2 119.5 (1.5) 72.0 (1)
Oyeyemi AY (64) 2015 Mercury 1 3 Average of 2nd & 3rd WHO, BP ≥ 125/80 11.2 2.4
Ratovoson R (65) 2015 Automated 1 2 Average JNC 7 7.4
Awotidebe A (66) 2016 Mercury 1 3 Average of 2nd & 3rd Fourth Report 8.7 4.3 105.3 (11.4) 68.6 (8.9)
Munthali RJ (67) 2016 Automated 1 2 Average Fourth Report & JNC7 34.9
Uwaezuoke SN (69) 2016 Mercury 1 3 Average Fourth Report & JNC7 10.7
Alicke M (70) 2017 Automated 1 3 Average of 2nd & 3rd Fourth Report 9 110 68
Bedu-Addo G (6) 2017 Automated 1 3 Average of 2nd & 3rd Fourth Report 10 110 (11) 68 (9)
Etyang AO (71) 2017 Automated 1 3 Average of 2nd & 3rd AHA 2014 4.2 117 (12) 64 (8)
Etyang AO (72) 2018 Automated + 24 h ABPM 2 3 Average of 2nd & 3rd AHA 2014 3.9 117 (11) 64 (7)
Ezeudu CE (73) 2018 Automated 2 3 Average of 2nd & 3rd Fourth Report 6.3 110.5 (10.2) 71.5 (8.5)
Isezuo KO (75) 2018 Mercury 3 3 Third measure Fourth Report 7.5 3.1 111.7 (13.2) 67.7 (9.6)
Leyvraz M (76) 2018 Automated 1 2 Average Fourth Report 8.5 111.6 (11.7) 68.4 (8.5)
Masocha V (77) 2018 Automated 1 2 Average IDF 9.7 5% over 3 years 103.2 (9.8) 67.7 (8.0)
Nakiriba R (78) 2018 Automated 1 3 Average 11.6
Omisore AG (79) 2018 Mercury 1 2 Average Fourth Report 4.1 102.9 (13.5) 66.0 (9.9)
Abu OO (80) (#201) 2019 1 Fourth Report 8.8 6.9 104.8 (14.8) 67.1 (10.5)
Adeomi AA (81) 2019 Automated 1 2 Average Fourth Report 32.9
Amponsem-Boateng C (82) 2019 Automated & Mercury 1 Average JNC 7 35 3.1
Chungag A (83) 2019 Automated 1 3 Average AAP 2017 12.2 20.7 111.5 (0.65) 71.9 (0.45)
Lule SA (#101) (85) 2019 Automated 1 3 Average of 2nd & 3rd Fourth Report 10.5 8.4 105.9 (8.3) 65.2 (7.3)
Abiodun O (90) 2019 Mercury 1 3 Average of 2nd & 3rd AAP 2017 25.3 25.1 118.6 (11.8) 68.3 (8.8)
Nkwana MR (88) 2019 Automated 1 2 Average 26.7 108.8 (13.5) 71.7 (11.3)
Nsanya MK (89) 2019 Automated 1 3 Average Fourth Report 22.0 15.0 36.8
Frigati L (84) 2019 Automated 1 Fourth Report 13.9 105.5 67.4
Azupogo F (91) 2020 Automated 1 3 Average of 2nd & 3rd Fourth Report 0.2 20.4 110.5 68.5
Katamba G (92) 2020 Automated 1 3 Average of 2nd & 3rd Fourth Report, ESH 2009, AHA 2017 7.1 3.1 113.3 (9) 66.5 (8.1)
Masocha V (93) 2020 Automated 1 2 Average IDF 5 103.5 (10.5) 66.7 (8.4)
Mokgwathi M (94) 2020 Automated 2 2 Average Fourth Report, JNC8 15.5 13.1 118 (13.2) 71.8 (9.5)
Raphadu TT (95) 2020 Automated 1 2 Average Fourth Report 27.1 8.7
Ugochukwu EF (97) 2020 Mercury 1 3 Average Third Report 11.0 8.5 110.6 (12.6) 70.5 (8.5)
Ukoh U (98) 2020 Automated & Mercury 1 3 Average Fourth Report & JNC 7 4.6 106.7 (11.4) 63.6 (7.3)
Sungwa EE (96) 2020 Automated 1 3 Average Fourth Report 21.4 113.4 65.4
Akinbodewa AA (99) 2021 Mercury 1 1 Fourth Report 13.2 13.2 106.2 (15.5) 63.7 (10.7)
Ayogu RN (100) 2021 Automated 1 2 Average AAP 2017 10.7 19
Chungag A (101) 2021 Automated 1 3 Average AAP 2017 5.1 32.8 111.8 72.1
DuPlessis JP (102) 2021 Finapres 1 Continuous Average AAP 2017 19 34 117 (13.3) 77 (9.2)
Letswalo BP (104) 2021 Automated 1 3 Average Fourth Report 15.5 23.3 115.9 (9.0) 72.7 (6.3)
Lwabukuna WC (105) 2021 Mercury 1 2 Average IDF 2.3 111.5 (8.7) 65.2 (5.9)
Meer R (106) 2021 Automated 3 Average Fourth Report 57 cases/1000 pyrs
Nganou-Gnindjio CN (107) 2021 Automated 1 3 Average AAP 2017/JNC8 11.1
Nsanya MK0 (4) 2021 Automated + 24 h ABPM 2 2 Average AAP 2017 10.2
Sekokotla AM (108) 2021 Automated 1 3 Average 11.8 19.7 31.6 117 71
Shokunbi OS (109) 2021 Mercury 1 3 Average AAP 2017 10.5 19.3 110.6 (13.7) 71.9 (11.0)

Second Report: National Heart, Lung and Blood Institute (NHLBI) task force report on blood pressure control in children (1987), children and adolescents up to 18 years.

Third Report: National Heart, Lung and Blood Institute (NHLBI) update on the 1987 task force report on high blood pressure in children and adolescents up to 18 years.

Fourth Report: National Heart, Lung and Blood Institute (NHLBI) task force report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents up to 17 years.

ESH 2009: European Society of Hypertension (ESH) on management of high blood pressure in children and adolescents up to 17 years.

AHA 2014: American Heart Association (AHA) update, A scientific statement on ambulatory BP monitoring in children and adolescents up to 17 years.

AAP 2017: American Academy of Paediatric—clinical practice guideline for screening and management of high blood pressure in children and adolescents up to 12 years.

JNC7: The Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure “he seventh report”—(adults ≥18years).

JNC8: The Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure “he eighth report”—(adults ≥18years).

WHO/ISH 1999: The World Health Organization—International Society of Hypertension Guidelines for Management of hypertension—(adults ≥18years).

IDF: The International Diabetes Federation (IDF) consensus definition metabolic syndrome—(adults ≥18years).

Of 79 studies shown in Table 2, 39 studies (49.4%) used automated BP machines, 33 studies (41.7%) used manual (mercury or aneroid) BP machines, 2 studies (2.6%) used both automated and manual BP machines, and 4 studies (5.1%) used Finapres (Finger artery pressure)—an automated device which records BP measurements “continuously” from a finger artery. Only 3 studies used 24-h ambulatory BP monitoring for confirming HTN (4, 71, 72).

Of the 79 studies, 71 (89.8%) had their BP measurements obtained in one day. Of those 71 studies, the number of BP measurement obtained in one day ranged from one in 6 studies (8.5%), two in 19 studies (26.8%) and three in 37 studies (52.1%). In addition, 5 studies (7.0%) collected more than 3 BP measurements (“continuous”), and this information was not reported in 4 studies (5.6%).

Of the 68 studies with more than one BP measurements, most studies 51(75.0%) used an average of all BP measurements to obtain final BP measure. In addition, 14 studies (20.5%) used an average of second and third BP measurements, 1 study (1.5%) only used second measurement, 1 study (1.5%) only used third measurement and this information was not reported in another 1 study (1.5%).

 Definitions of hypertension

Of the 77 studies with information on standard guidelines used for defining HTN (Table 2), 58 (75.3%) used one of the six American guidelines for the diagnosis and management of HTN in children and adolescents. The 2004 “Fourth Report” was the most commonly used version in 39 studies (50.6%) (110). In addition, the fixed BP cut-offs for defining HTN in adults were used in 10 studies (13.0%), often in older adolescents aged 18 years and above. Fewer studies used the z-distribution (n = 3) and the International Diabetes Federation definitions (n = 3).

Guidelines for defining HTN among adolescents have evolved over the years (Supplementary Appendix 3) provides a summary of the guidelines that were used for diagnosing HTN in the included studies. Overall, the aim for guideline revisions over the years was to account for age, height, and sex differences in BP thresholds for HTN. Also, in particular to American guidelines, the reference population size has increased from about 9,000 in 1977 to nearly 50,000 adolescents with normal BMI and percentile thresholds for HTN have decreased in the most recent guidelines (11).

 Prevalence and incidence of HTN

Of the 92 studies, 78 studies (84.6%) reported estimates for prevalence of pre-hypertension and/or elevated BP and/or HTN with only 2 studies reporting incidence of HTN (Table 2). The incidence of HTN was estimated at 5% over 2 years (77) and 57 cases per 1,000 person-years (106).

The prevalence of pre-hypertension was reported in 27 studies and ranged from 1.5% to 35%, with median (IQR) = 11.8% (8.7%, 15.5%). The prevalence of HTN was reported in 65 studies and ranged from 0.18% to 34.0%, with median (IQR) = 5.5% (3.1%, 11.1%); while the prevalence of elevated BP (combined pre-hypertension and HTN) was reported in 18 studies and ranged from 0.6% to 36.8%, and median (IQR) = 20.8% (10.2%, 31.6%).

 Prevalence of HTN across the four African regions in sub-Saharan Africa

Of all 65 studies with information on prevalence of HTN, studies from south African region (n = 13) had higher HTN prevalence, median (IQR) of 13.9% (5.1% to 21.2%), followed by west African region with a median (IQR) of 4.5% (2.6% to 9.5%), east African region with a median (IQR) of 4.2% (3.1% to 8.4%), and central African region with a median (IQR) of 3.1% (3.1% to 3.1%).

Factors associated with prevalence of HTN

Overall, studies in which BP measurements were obtained using automated BP devices (n = 31) had significantly higher mean HTN prevalence (11.1% (95% CI: 8.2%–14.1%)), than those using manual devices—Mercury or Aneroid BP machines (n = 31) (5.4% (95% CI, 3.6%–7.2%)) (p = 0.0006) (Figure 2).

Box and whiskers plot showing the distribution of hypertension prevalence across the 2 types of BP measurement device.

Similarly, studies in which HTN was defined using cut offs based on a percentile BP distribution according to age, sex, and height (n = 43) had significantly higher mean HTN prevalence (8.7% (95% CI: 6.7%–10.7%)), than those using cut-offs based a fixed BP measure (n = 14), (3.8% (95% CI: 1.9%–5.6%)) (p = 0.004) (Figure 3).

Box and whiskers plot showing the distribution of hypertension prevalence across 2 types of hypertension definition.

There were statistically significant differences between mean HTN prevalence across the four sub Saharan Africa regions (F = 7.49, p = 0.0002). However, there was no significant difference in mean HTN prevalence across study settings (rural, rural/urban and urban) (Figures 4A,B).

(A) Box and whiskers plot showing the distribution of hypertension prevalence across the study settings. (B) Box and whiskers plot showing the distribution of hypertension prevalence across the different SSA regions.

There was a significant positive correlation between HTN prevalence, and year of study publication (n = 64, Pearson Correlation coefficient “r” = 0.4, p = 0.0009) (Figure 5).

Scatter plot showing the relationship between hypertension prevalence and year of study publication.

In an adjusted meta regression analysis model (including year of publication, study settings, African region, type of BP measurement device used, and criteria for defining HTN), the year of publication (β = 0.14%, 95% CI: −0.003% to 0.28%, p = 0.05) and African regions (F = 3.95, p = 0.01) remained significantly associated with higher prevalence of hypertension. (Adjusted R2 = 0.38). Additionally, on average HTN prevalence estimates from Southern Africa were higher by 6.05%, 95% CI (1.97% to 10.13%, p = 0.005) than those from Western Africa.

 Risk factors for hypertension

Table 3 summarizes common risk factors for HTN among adolescents in SSA. Of all 92 studies, 79 (85.9%) assessed at least one kind of traditional and/or non-traditional risk factor, and a majority (79.7%) were cross-sectional studies. Most of the reported risk factors were significantly associated with HTN although some of the associations were in an unexpected direction (82, 91, 100).

Risk factors for hypertension among adolescents aged 10–19 years in sub-Saharan Africa.

Traditional risk factors
Risk factor With significant association Without significant association
Body Mass Index (BMI) and other anthropometric measures {n = 60} Overweight/Obesity {n = 23} (39, 45, 46, 52, 54, 57, 58, 71–73, 76, 77, 82, 85, 88, 90, 91, 100, 102, 104, 106, 108, 109)Higher BMI {n = 12} (38, 59, 62, 66, 69, 79, 81, 83, 89, 96, 97, 106)Waist circumference: Higher waist circumference {n = 6} (46, 66, 69, 83, 90, 104)Waist to height ratio: Higher waist to height ratio {n = 4} (66, 81, 90, 104)Waist to hip ratio: Higher waist to hip ratio {n = 1} (69)Neck circumference: increasing neck circumference {n = 1} (92)Thigh circumference: higher thigh circumference {n = 1} (104)Body fat percentage: higher body fat percentage {n = 2} (46, 66) BMI {n = 9} (4, 32, 43, 63, 70, 92, 94, 98, 107)Stunted growth {n = 1} (37)
Sex {n = 53} Female {n = 16} (39, 43, 58, 64, 70, 72, 73, 76, 83, 85, 91, 94, 97, 107, 109)Male {n = 9} (24, 71, 75, 89–92, 94, 95) {n = 27} (24, 26, 30, 31, 36, 38, 41, 42, 45, 52–54, 60, 66, 75, 77, 79, 81, 88, 90, 95, 96, 99, 106, 108, 111)
Age {n = 45} Older {n = 31} (31, 32, 37, 41, 43, 53, 63, 64, 70, 94, 98, 99, 107)Younger {n = 1} (100) {n = 13} (24, 38, 45, 56, 66, 75, 81, 85, 90, 91, 95, 108)
Substance use/abuse {n = 8} Cigarette smoking {n = 1} (94); Alcohol drinking {n = 4} (81, 92, 98, 100) Cigarette smoking {n = 1} (59)Alcohol drinking {n = 1} (89)
Diet {n = 9} Macronutrients: Deficiency in protein; Skipping meals daily (35, 100)Micronutrients: Deficiency in biotin B7, folic acid, pantothenic acid B5, zinc, vitamin & Energy; vitamin A, vitamin C, vitamin E, nicotinic acid, vitamin B12, biotin and phosphorus (35, 70)Sugar, salt and fat: Adding table salt; higher egg consumption; polyunsaturated fats; fried food; soft drinks; high sugar consumption > 10 teaspoons per day; eating fried/baked snacks (4, 96, 100, 109)Vegetables and fruits: low fruit and vegetable consumption; fibre (35, 89, 109)
Physical inactivity {n = 7} Physical inactivity {n = 4} (38, 77, 82, 97)Higher frequency of watching Television—protective among girls {n = 1} (91) {n = 2} (4, 100)
Cardiometabolic risk factors {n = 7} Cardiometabolic risks tend to cluster among females {n = 1} (70); lower eGFR {n = 1} (71); Higher pulse wave velocity {n = 2} (71, 104); Higher fasting glucose {n = 1} (104); high resting pulse >90bpm {n = 1} (4)
Heredity {n = 8} Genes—NOSIAP, MYRE, POC1B {n = 1} (74)Family history of hypertension {n = 5} (39, 54, 85, 92, 107) Genes {n = 1} (86)Family history of hypertension {n = 1} (58)
Non-traditional risk factors
Socioeconomic factors (n = 21) Higher SES: Higher parental education {n = 2} (30, 85); higher socioeconomic class {n = 3} (42, 75, 98); parent income {n = 1} (64); Attending private school {n = 2} (73, 96); living in urban area {n = 2} (45, 79); owning land—protective {n = 1}; (91)Lower SES: Living in rural area {n = 1} (96); Lower socioeconomic status {n = 4} (43, 52, 91, 97);Environmental factor: Winter weather {n = 1} (101) Parental education {n = 1} (64); parent occupation {n = 1} (64); higher socioeconomic class {n = 1} (29); Attending private school {n = 1} (58); lower social class {n = 1} (58); indoor particulate matter pollution {n = 1} (101); Living in rural area {n = 1} (101)
Maternal and Natal factors {n = 15} Maternal factors: Maternal exposure to MeHg {n = 1} (111); Maternal hypertension {n = 1} (111); Malaria in pregnancy {n = 1} (6); Younger maternal age {20—29years}—protective {n = 1} (52); higher maternal gestation BMI {n = 1} (85);Natal factors: Low birth weight {n = 1} (34); Weight gain in first year of life {n = 1} (47); Postnatal and childhood weight gain {n = 2} (41, 87); Born post-term {n = 1} (52); High BP at young ages {n = 2} (14, 76); Birth weight {n = 1} (47); Maternal supplementation with calcium and protein from second trimester {n = 1} (48); stunted growth {n = 1} (37)
Blood disorders {n = 5} Higher haemoglobin concentration {n = 1} (90); low serum magnesium and low-grade inflammation—high-sensitive C-reactive protein {n = 1} (108); low serum potassium {n = 1}; blood homocysteine {n = 1} (102) Sickle cell {n = 1} (72); Alpha thalassemia {n = 1} (71)
Endemic infections {n = 3} HIV infection—lower SBP {n = 1} (84); Childhood Malaria infection—lower SBP {n = 1} (47); Whipworm infestation—higher SBP {n = 1} (87)
Traditional risk factors

Sex (n = 53), age (n = 45), body mass index (n = 45), and other anthropometric measures (n = 15) were the most commonly studied traditional risk factors for HTN. Other important traditional risk factors include alcohol/tobacco use (n = 8), diet (n = 9), level of physical activity (n = 7), genetic (n = 7), and cardiometabolic risk factors (n = 7)—Table 3.

Sex: Of 53 studies, nearly half 26 (49%) showed a significant association with HTN. Of those 26 studies, a slight majority 16 (62%) showed that females had a higher risk of HTN than males, and obesity and an unhealthy diet were the major factors to account for the gender differences.

Age: Of 45 studies, a majority 32 (71%) showed a significant association with HTN, and 97% of these 32 studies showed that older age was associated with HTN.

Body Mass Index (BMI) and other anthropometric measures: Of 59 studies, a majority 49 (83%) had a significant association with HTN. However, 10 (17%) studies did not find a significant association with HTN. These 10 studies were all cross-sectional, school-based, and the majority were conducted in urban settings.

Diet: All 9 studies reporting on various dietary factors found significant associations with HTN. The studies assessed a deficiency of macronutrients, micronutrients, and minerals; excessive consumption of sugar, salt, and fats; and low consumption of vegetables and fruits.

Physical inactivity: Of 7 studies, 4 (71%) found a significant association between physical inactivity and HTN. However, 1 study (14%) surprisingly showed that physical inactivity was associated with normal BP.

Cardiometabolic risk factors: All 7 studies reporting various cardiometabolic risks found significant associations with HTN. The identified cardiometabolic risk factors were lower eGFR, higher pulse wave velocity, high fasting glucose, high resting pulse, and higher blood homocysteine, and these risk factors tended to cluster in females.

Heredity: Of 8 studies, 6 (75%) showed a significant association with HTN. However, the majority 5 (83%) relied on self-reported family history of HTN. Importantly, one study using human genome data from the Birth to Twenty cohort (South Africa) showed that the NOSIAP, MYRE, and POCIB genes were associated with HTN in South African adolescents.

 Non-traditional risk factors

These are factors related to socio-economic environmental and endemic diseases which are related to HTN.

Socioeconomic status and environmental factors (n = 21) as well as maternal and natal factors (n = 15) were the most commonly reported non-traditional risk factors. Other important non-traditional risks were chronic inflammation, blood composition, diseases of the blood (n = 5), and endemic infections (n = 3) (Table 3).

Socioeconomic and environmental factors: Of 21 studies, 17 (81%) found a significant association between socioeconomic and environmental factors with HTN. Of the 17 studies, 12 (71%) found higher socioeconomic status and 5 (29%) found lower socioeconomic as a significant risk for HTN.

Maternal and natal factors: Of 15 studies, majority 12 (80%) found a significant association between maternal and natal factors with HTN. Of the 12 studies, 5 (42%) assessed maternal factors, including events before or during pregnancy, including maternal exposure to mercury, maternal HTN, and malaria in pregnancy. Seven studies (58%) assessed the association between events occurring during or after birth, including low birth weight, weight gain after birth and during early childhood, and higher BP at a young age.

Blood disorders: Of 5 studies, 3 (60%) found a significant association with HTN. Of the 3 studies, the reported risks were higher hemoglobin concentration (90), lower serum magnesium (108), lower serum potassium, and higher C-reactive protein levels (102, 109).

Endemic infections: Of the 3 studies on HIV, malaria and whipworm infestation, only whipworm infestation was significantly associated with HTN (85).

 Complications of hypertension

Only 3 studies assessed potential complications of HTN among adolescents in SSA. Two studies found no significant association between HTN and cognitive decline (57), proteinurias, left ventricular hypertrophy, and retinopathy (39). One study found a significant association between HTN and microalbuminuria (54) (Table 4).

Summary of studies on complication of hypertension among adolescents aged 10–19 years in sub-Saharan Africa.

Author Year Sample size Prevalence of complication (end organ damage) Association with hypertension
Lyngdoh (57) 2013 407 Cognitive decline using multiple cognitive tests Not significant
Mijinyawa (39) 2008 968 Proteinuria (30 mg/dl)—present in 15 (21.4%) out of 70 with high BP. Not significant
Left ventricular hypertrophy—present in 0 (0%) out of 41 with high BP and available for ECG.
Retinopathy—present in 0 (0%) out of 70 with high BP and available for fundoscopy.
Okpere (54) 2012 615 Microalbuminuria—present in 12 (70.6%) out of 17 with hypertension Significant (p = 0.001)
Discussion

In this systematic review, we aimed to determine the burden, risk factors, and complications of HTN among adolescents in SSA.

The prevalence of HTN among adolescents in SSA was found to be high with varying estimates across studies. Overall, prevalence estimates from recently published studies were higher than those published in the past. This finding persisted even after taking into account of other possible reasons including differences in the devices used to measure BP and guidelines for defining HTN. In addition, studies with significantly higher prevalence estimates came from Southern Africa region, and overweight/obesity among girls was the major reported risk factor (62, 83, 88, 103, 104). Similar findings were observed in the previous systematic reviews (17, 18). The finding suggests that the burden of HTN is increasing and could explain the rising burden of CVD among young adults (17, 18, 112–114).

Nearly 90% of the included studies had their BP measurements obtained in one day contrary to the standard recommendations which require taking multiple BP measurements on at least 2 separate occasions (days) (11, 110). This raises concern about the accuracy of the HTN prevalence estimates and a potential possibility of an overestimated HTN burden (3). Adolescents are more likely than adults to experience white coat HTN (4, 115, 116). Moreover, majority of adolescents in SSA have never had their BP measured and are therefore more prone to the “white coat effect”, particularly when the BP measurements are taken on one occasion (4). This observation underscores the importance of following the standard BP measurement procedures particularly in this population to ensure accurate estimates.

Non-traditional risk factors related to poverty and tropical diseases may be important drivers of HTN among adolescents in SSA despite being under-reported and/or their role being less acknowledged (6, 15). We found relatively fewer studies that assessed/reported non-traditional risk factors, likely reflecting low awareness of their potential role on HTN in this population. In addition, the scarcity of long-term cohort studies among adolescents in SSA could partly explain this finding since most of the non-traditional risks involve tracking long term exposures occurring in one's lifetime (5, 15, 85, 87). However, it is worth noting that majority of studies assessing non-traditional risk factors often reported significant associations with HTN. This observation underscores the importance of the non-traditional risk factors although we cannot rule out publication bias.

The majority of the included studies were conducted in school settings among apparently healthy adolescents. This finding may reflect the willingness of schools and/or students to participate in research and health related interventions. It highlights the importance of schools as a potentially suitable platform for CVD prevention interventions targeting adolescents (117). Such interventions could be integrated into existing school health programs, and address multiple aspects of cardiovascular health including a healthy diet, physical exercise, and body weight control (117). BP measurement in schools might also help to raise awareness of the relevance of cardiovascular health for adolescents among teachers, parents, and entire communities. In addition, this finding points to the scarcity of hospital-based studies among adolescents in SSA where the epidemiology of HTN could be different.

Only three studies assessed/reported potential complications of HTN among adolescents in SSA (39, 54, 57), and mostly they found little or no complications. This may be due to using less-sensitive tools for the detection of HTN-related complications. For instance, in one of the three studies, left ventricular hypertrophy was assessed by electrocardiography which is known to have a sensitivity of less than 35% (39, 118). Tools with higher sensitivity and specificity to increase our awareness and knowledge of complications of HTN will help to determine the public health importance of HTN among adolescents in SSA.

Our study should be viewed in the context of the following strengths and limitations. A strength of our study is that we searched from multiple databases since their inception (from 1946). The wider review time frame allowed us to retrieve more studies published at widely ranging time points, hence giving a wider scope on how HTN estimates and their determinants have evolved over time. Our review focused on studies involving adolescents, and our findings provide useful information specific to this population. This is the first review to look at potential role of non-traditional risk factors and complications of hypertension among adolescents in SSA.

Our study has limitations. First, the retrieved studies came from only 14 (29%) of all 48 countries in SSA. The majority of studies came from Nigeria and South Africa, which are the two most advanced economies in SSA. Further, there were significant differences in prevalence estimates by African regions from which the studies came from. In this regard, our findings may not be generalizable to all countries in SSA. Secondly, a majority of studies were cross-sectional in design and therefore it is difficult to determine the temporal association with the reported risk factors. Thirdly, we cannot rule out publication bias, particularly for studies assessing/reporting non-traditional risk factors. And lastly, we did not conduct meta-analysis due to heterogeneity in study methods and settings/geography among the included studies.

Added value and implications of these findings

To our understanding, this is the second systematic review including adolescent only data in SSA region (16). Our review is updating the previous three reviews and has mapped available literature in SSA and highlighted existing knowledge/data gaps (16–18). These findings underscore the importance of accurate BP measurement and diagnosis of HTN in adolescents, both in research and clinical settings. Since HTN during adolescence is associated with the growing HTN/CVD epidemic among adults, broadly these findings will help us to design a CVD prevention intervention targeting adolescents in SSA, particularly in school settings.

 Conclusion

HTN among adolescents in SSA is high, and non-traditional risk factors may be an important driver. Longitudinal observational and interventional studies are needed to clearly define the causes and complications of HTN in adolescents in SSA. In addition, governments and healthcare systems should provide the resources and accountability necessary for regular and proper BP measurements for adolescents in health facilities.

 Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

 Author contributions

All authors had access to data extraction sheets and data analysis outputs. All authors contributed to the article and approved the submitted version.

 Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2023.1251817/full#supplementary-material

SUPPLEMENTARY DATA SHEET 1

Search methods for rates, risk factors, and consequences of high blood pressure among adolescents in sub-Saharan Africa.

SUPPLEMENTARY DATA SHEET 2

List of publications whose full texts were not immediately available for review.

SUPPLEMENTARY DATA SHEET 3

Summary table of hypertension guidelines used in published studies among adolescents aged 10–19 years in sub-Saharan Africa.

 References SongPZhangYYuJZhaMZhuYRahimiK Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. (2019) 173(12):1154–63. 10.1001/jamapediatrics.2019.331031589252 UNICEF. The state of World’s Children—Investing in adolescents for breaking the cycles of poverty and inequity (2011). Available at: https://www.unicef.org/reports/state-worlds-children-2011 FalknerB. Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. (2010) 25:1219–24. 10.1007/s00467-009-1200-319421783 NsanyaMKAyiekoPHashimRMgemaEFitzgeraldDKapigaS Sustained high blood pressure and 24-h ambulatory blood pressure monitoring in Tanzanian adolescents. Sci Rep. (2021) 11:8397. 10.1038/s41598-021-87996-033864003 AlissaEMFernsGA. Heavy metal poisoning and cardiovascular disease. J Toxicol. (2011) 2011:870125–46. 10.1155/2011/87012521912545 Bedu-AddoGAlickeMBoakye-AppiahJKAbdul-JalilIvan der GietMSchulzeMB In utero exposure to malaria is associated with metabolic traits in adolescence: the agogo 2000 birth cohort study. J Infect. (2017) 75(5):455–63. 10.1016/j.jinf.2017.08.01028851533 BrookRDWederABRajagopalanS. “Environmental hypertensionology” the effects of environmental factors on blood pressure in clinical practice and research. J Clin Hypertens. (2011) 13(11):836–42. 10.1111/j.1751-7176.2011.00543.x MandyMNyirendaM. Developmental origins of health and disease: the relevance to developing nations. Int Health. (2018) 10(2):66–70. 10.1093/inthealth/ihy00629528398 RajagopalanSLandriganPJ. Pollution and the heart. N Engl J Med. (2021) 385(20):1881–92. 10.1056/nejmra203028134758254 FishmanBGrossmanEZuckerIOrrOLutskiMBardugoA Adolescent hypertension and risk for early-onset type 2 diabetes: a nationwide study of 1.9 million Israeli adolescents. Diabetes Care. (2020) 44(1):e6–8. 10.2337/dc20-175233148634 FlynnJTFalknerBE. New clinical practice guideline for the management of high blood pressure in children and adolescents. Hypertension. (2017) 70(4):683–6. 10.1161/HYPERTENSIONAHA.117.1005028827475 LeibaAFishmanBTwigGGiladDDerazneEShamissA Association of adolescent hypertension with future end-stage renal disease. JAMA Intern Med. (2019) 179(4):517–23. 10.1001/jamainternmed.2018.763230801616 UrbinaEMMendizábalBBeckerRCDanielsSRFalknerBEHamdaniG Association of blood pressure level with left ventricular mass in adolescents SHIP AHOY. Hypertension. (2019) 74(3):590–6. 10.1161/HYPERTENSIONAHA.119.1302731327264 KaguraJAdairLSMusaMGPettiforJMNorrisSA. Blood pressure tracking in urban black South African children: birth to twenty cohort. BMC Pediatr. (2015) 15(1):78–85. 10.1186/s12887-015-0402-z26173634 NaidooSKaguraJFabianJNorrisSACommentarySE. Early life factors and longitudinal blood pressure trajectories are associated with elevated blood pressure in early adulthood. Hypertension. (2019) 73(2):301–9. 10.1161/HYPERTENSIONAHA.118.1199230580689 ChenAWaiteLMocumbiAOChanYKBeilbyJOjjiDB Elevated blood pressure among adolescents in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. (2023) 11(8):e1238–48. 10.1016/S2214-109X(23)00218-837474231 CrouchSHSoepnelLMKolkenbeck-RuhAMaposaINaidooSDaviesJ Paediatric hypertension in Africa: a systematic review and meta-analysis. EClinicalMedicine. (2022) 43:101229. 10.1016/j.eclinm.2021.10122934917909 NoubiapJJEssoumaMBignaJJJingiAMAmindeLNNansseuJR. Prevalence of elevated blood pressure in children and adolescents in Africa: a systematic review and meta-analysis. Lancet Public Health. (2017) 2(8):e375–86. 10.1016/S2468-2667(17)30123-829253478 BramerWMRethlefsenMLKleijnenJFrancoOH. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev. (2017) 6(1):1–12. 10.1186/s13643-017-0644-y28077170 Grossetta NardiniHKWangL. The Yale MeSH Analyzer (2018). http://mesh.med.yale.edu/ WellsGSheaBO’ConnellDPetersonJWelchVLososM Newcastle-Ottawa Quality Assesment Scale Cohort Studies (2021). Available at: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCD The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. 10.1136/bmj.n7133782057 AkinkubeOOOjoAO. The systemic blood pressure in a rural Nigerian population. Trop Geogr Med. (1968) 20:347–56.5707221 JohnsonTO. Arterial blood pressures and hypertension in an urban African population sample. Br J Prev Soc Med. (1971) 25(1):26–33. 10.1136/jech.25.1.265551230 AkinkugbeA. Arterial pressures in non-pregnant women of child-bearing age in Ile-Ife, Nigeria. Br J Obstet Gynaecol. (1976) 83:545–9. 10.1111/j.1471-0528.1976.tb00883.x952782 Ayobanji AyoolaE. Prevalence of adolescent hypertension in Nigeria. Niger J Paediatr. (1979) 6(1):18–26. Abu-BakareAOyaideSM. Blood pressure levels in Nigerian school girls. J Trop Pediatr. (1983) 29:225–9. 10.1093/tropej/29.4.2256632045 IdahosaPE. Blood pressure pattern in urban edos. J Hypertens. (1985) 3(Suppl. 3):S379–81. PMID: 2856744. EferakeyaAE. Arterial blood pressures in Benin city (Nigeria) children. Public Health. (1986) 100(3):174–9. 10.1016/S0033-3506(86)80031-23737865 Adams-CampbellLLUkoliFYoungMPOmeneJNwankwoMHaileGT An epidemiological assesment of blood pressure determinants in an adolescent population of Nigerians. J Hypertens. (1987) 5:575–80. 10.1097/00004872-198710000-000113429862 KitangeHMSwaiABMMasukiGKilimaPMAlbertiKGMMMcLartyDG. Coronary heart disease risk factors in sub-Saharan Africa: studies in Tanzanian adolescents. J Epidemiol Community Health. (1993) 47(4):303–7. 10.1136/jech.47.4.3038228767 MuraguriPWMcLigeyoSOKayimaJK. Proteinuria, other slected urinary abnormalities and hypertension among teenage secondary school students in Nairobi, Kenya. East Afr Med J. (1997) 74(8):467–73. PMID: 9487409.9487409 KaneADiofN. Arterial pressure and body mass index of children and adolescents in a rural area of Thiadiaye, Senegal. Dakar Med. (1998) 43:83–9. PMID: 9827163.9827163 Longo-MbenzaBNgiyuluRBayekulaMVitaEKNkiabunguFBSeghersKV Low birth weight and risk of hypertension in African school children. J Cardiovasc Risk. (1999) 6(5):311–4. 10.1177/20474873990060050710534134 SchutteAEVan RooyenJMHuismanHWKrugerHSMalanNTDe RidderJH. Dietary risk markers that contribute to the aetiology of hypertension in black South African children: the THUSA BANA study. J Hum Hypertens. (2003) 17(1):29–35. 10.1038/sj.jhh.100150812571614 SchutteAEVan RooyenJMHuismanHWKrugerHSDe RidderJH. Factor analysis of possible risks for hypertension in a black South African population. J Hum Hypertens. (2003) 17(5):339–48. 10.1038/sj.jhh.100155312756407 Van RooyenJMKrugerHSHuismanHWSchutteAEMalanNTSchutteR. Early cardiovascular changes in 10- to 15-year-old stunted children: the transition and health during urbanization in South Africa in children study. Nutrition. (2005) 21(7–8):808–14. 10.1016/j.nut.2004.12.00715975488 ChioleroAMadeleineGGabrielABurnierMPaccaudFBovetP. Prevalence of elevated blood pressure and association with overweight in children of a rapidly developing country. J Hum Hypertens. (2007) 21(2):120–7. 10.1038/sj.jhh.100212517136104 MijinyawaMSIliyasuZBorodoMM. Prevalence of hypertension among teenage students in Kano, Nigeria. Niger J Med. (2008) 17(2):173–8. 10.4314/njm.v17i2.3737818686834 MonyekiKDKemperHCGMakgaePJ. Relationship between fat patterns, physical fitness and blood pressure of rural South African children: ellisras longitudinal growth and health study. J Hum Hypertens. (2008) 22(5):311–9. 10.1038/jhh.2008.318273041 CournilAColyANDialloASimondonKB. Enhanced post-natal growth is associated with elevated blood pressure in young Senegalese adults. Int J Epidemiol. (2009) 38(5):1401–10. 10.1093/ije/dyp25519661279 MijinyawaMSAbduAHabibA. Pattern of blood pressure in adolescents. Sahel Med J. (2009) 12(4):159–64. 10.4314/smj2.v12i4.55694 OdeyFAnahMAnsaVOgbecheJMeremikwuMEkanemE. Pre-hypertension and hypertension in apparently healthy adolescents in Calabar, Nigeria. Global J Commun Med. (2009) 2(1–2):13–20. 10.4314/gjcm.v2i1-2.47924 AnsaVAnahMOdeyFMbuPAgborE. Relationship between parental socio-economic Status and casual blood pressure in coastal Nigerian adolescents. West Afr J Med. (2011) 29(3):146–52. 10.4314/wajm.v29i3.68211 EjikeCECCUgwuCEEzeanyikaLUS. Variations in the prevalence of point (pre)hypertension in a Nigerian school-going adolescent population living in a semi-urban and an urban area. BMC Pediatr. (2010) 10:13. 10.1186/1471-2431-10-1320214768 KrugerHSPretoriusRSchutteAE. Stunting, adiposity, and low-grade inflammation in African adolescents from a township high school. Nutrition. (2010) 26(1):90–9. 10.1016/j.nut.2009.10.00420005466 ChioleroAParadisGMadeleineGHanleyJAPaccaudFBovetP. Birth weight, weight change, and blood pressure during childhood and adolescence: a school-based multiple cohort study. J Hypertens. (2011) 29(10):1871–9. 10.1097/HJH.0b013e32834ae39621881523 HawkesworthSWalkerCGSawoYFulfordAJCJarjouLMAGoldbergGR Nutritional supplementation during pregnancy and offspring cardiovascular disease risk in the Gambia. Am J Clin Nutr. (2011) 94(6):1853. 10.3945/ajcn.110.000877 MamaboloRVan RooyenJSchutteAMonyekiMKrugerH. Association between blood pressure, measures of body composition and lifestyle factors in township adolescents, North-West Province, South Africa. Afr J Phys Health Educ Recreat Dance. (2011) 17(1):51–68. 10.4314/ajpherd.v17i1.65245 MeehanKABankoskiAJTejanEAnsumanaRBanguraUStengerDA Hypertension in Bo, Sierra Leone. Ethn Dis. (2011) 21(2):237–42. PMID: 21749030.21749030 BukabauJBMakuloJRRPakasaNMCohenEPLepiraFBKayembePK Chronic kidney disease among high school students of Kinshasa. BMC Nephrol. (2012) 13:24–9. 10.1186/1471-2369-13-2422559052 GriffithsPLSheppardZAJohnsonWCameronNPettiforJMNorrisSA. Associations between household and neighbourhood socioeconomic status and systolic blood pressure among urban South African adolescents. J Biosoc Sci. (2012) 44(4):433–58. 10.1017/S002193201200010722490826 OkohBAAlikorEAAkaniN. Prevalence of hypertension in primary schoolchildren in Port Harcourt, Nigeria. Paediatr Int Child Health. (2012) 32(4):208–12. 10.1179/2046905512Y.000000003923164295 OkpereANAnochieICEkeFU. Prevalence of microalbuminuria among secondary school children. Afr Health Sci. (2012) 12(2):140–7. 10.4314/ahs.v12i2.1023056019 OyewoleOOOritogunKS. Pre-hypertension and hypertension in adolescence: how much does it occur in a Nigerian community? West Afr J Med. (2012) 31(2):71–5. http://www.ncbi.nlm.nih.gov/pubmed/2320847323208473 GoonDAmusaLMhlongoDKhozaLAny-AnwuF. Elevated blood pressure among rural South African children in Thohoyandou, South Africa. Iran J Public Health. (2013) 42(5):489–96. http://ijph.tums.ac.ir23802106 LyngdohTViswanathanBKobroslyRVan WijngaardenEHuberBDavidsonPW Blood pressure and cognitive function: a prospective analysis among adolescents in Seychelles. J Hypertens. (2013) 31(6):1175–82. 10.1097/HJH.0b013e328360417623572201 OkpereANAnochieICEkeFU. Pattern of blood pressure and hypertension in adolescents in Port Harcourt, Nigeria. West Afr J Med. (2013) 32(2):93–8. PMID: 23913495.23913495 UjunwaFAIkefunaANNwokochaARChinawaJM. Hypertension and prehypertension among adolescents in secondary schools in Enugu, South East Nigeria. Ital J Pediatr. (2013) 39:1–6. 10.1186/1824-7288-39-7023311474 MushengeziBChilloP. Association between body fat composition and blood pressure level among secondary school adolescents in Dar es Salaam, Tanzania. Pan Afr Med J. (2014) 19:327–38. 10.11604/pamj.2014.19.327.522225918567 OkaguaJAkaniN. Prevalence of hypertension in school going adolescents in rural areas of Rivers State, South-South Nigeria. Niger Health J. (2014) 14(4):157–64. Nkeh-ChungagBSekokotlaAM. Prevalence of hypertension in 13–17 years old in MTHATHA South Africa. Cent Eur J Public Health. (2015) 23(1):59–64. 10.21101/cejph.a392226036100 OdunaiyaNALouwQAGrimmerKA. Are lifestyle cardiovascular disease risk factors associated with pre-hypertension in 15–18 years rural Nigerian youth? A cross sectional study. BMC Cardiovasc Disord. (2015) 15(1):144–54. 10.1186/s12872-015-0134-x26537355 OyeyemiAYUsmanMAOyeyemiALJaiyeolaOA. Casual blood pressure of adolescents attending public secondary schools in Maiduguri, Nigeria. Clin Hypertens. (2015) 21(3):16–21. 10.1186/s40885-015-0026-526893926 RatovosonRRasetarineraORAndrianantenainaIRogierCPiolaPPacaudP. Hypertension, a neglected disease in rural and urban areas in Moramanga, Madagascar. PLoS One. (2015) 10:9. 10.1371/journal.pone.0137408 AwotidebeAMonyekiMAMossSJStrydomGLAmstrongMKemperHCG. Relationship of adiposity and cardiorespiratory fitness with resting blood pressure of South African adolescents: the PAHL study. J Hum Hypertens. (2016) 30(4):245–51. 10.1038/jhh.2015.8126202691 MunthaliRJKaguraJLombardZNorrisSA. Childhood adiposity trajectories are associated with late adolescent blood pressure: birth to twenty cohort. BMC Public Health. (2016) 16(1):665–75. 10.1186/s12889-016-3337-x27473865 StrassmanBISmithCSVincenzC. Does puberty influence systolic blood pressure independent of the effects of adolescent growth and body size? Am J Phys Anthropol. (2016) 159:305. 10.1002/ajpa.22955 UwaezuokeSOkoliCUbesieAIkefunaA. Primary hypertension among a population of Nigerian secondary school adolescents: prevalence and correlation with anthropometric indices: a cross-sectional study. Niger J Clin Pract. (2016) 19(5):649–54. 10.4103/1119-3077.18870627538555 AlickeMBoakye-AppiahJKAbdul-JalilIHenzeAVan Der GietMSchulzeMB Adolescent health in rural Ghana: a cross-sectional study on the co-occurrence of infectious diseases, malnutrition and cardio-metabolic risk factors. PLoS One. (2017) 12(7):e0180436–51. 10.1371/journal.pone.018043628727775 EtyangAOKhayeka-WandabwaCKapesaSMuthumbiEOdipoEWamukoyaM Blood pressure and arterial stiffness in Kenyan adolescents with α+thalassemia. J Am Heart Assoc. (2017) 6(4):e005613–20. 10.1161/JAHA.117.00561328381468 EtyangAOWandabwaCKKapesaSMuthumbiEOdipoEWamukoyaM Blood pressure and arterial stiffness in Kenyan adolescents with the sickle cell trait. Am J Epidemiol. (2018) 187(2):199–205. 10.1093/aje/kwx23228992220 EzeuduCEChukwukaJOEbenebeJCIgweWCEgbuonuI. Hypertension and prehypertension among adolescents attending secondary schools in urban area of South-east, Nigeria. Pan Afr Med J. (2018) 31:145–54. 10.11604/pamj.2018.31.145.1599431037205 HendryLMSahibdeenVChoudhuryANorrisSARamsayMLombardZ. Insights into the genetics of blood pressure in black South African individuals: the birth to twenty cohort. BMC Med Genom. (2018) 11:2. 10.1186/s12920-018-0321-6 IsezuoKOJiyaNMAuduLIIbitoyePKSaniUMYusufT Blood pressure pattern and the relationship with body mass index among apparently healthy secondary—school students in Sokoto Metropolis, Nigeria. SAJCH S Afr J Child Health. (2018) 12(3):105–10. 10.7196/SAJCH.2018.v12i3.1475 LeyvrazMWahlenRBloetzerCParadisGBovetPChioleroA. Persistence of elevated blood pressure during childhood and adolescence: a school-based multiple cohorts study. J Hypertens. (2018) 36(6):1306–10. 10.1097/HJH.000000000000169929517559 MasochaVCzyżSHMossSJMonyekiAM. Two-year changes in body composition, physical activity and selected metabolic risk factors among adolescents living in tlokwe municipality area, north west province, South Africa: the PAHL study. S Afr J Res Sport Phys Educ Recreation. (2018) 40(2):99–114. 10.1123/jpah.2018-0535 NakiribaRMayegaRWPiloyaTNabukeera-BarungiNIdroR. Prevalence and factors associated with dysglycemia among girls in selected boarding secondary schools in Wakiso district, Uganda. Adolesc Health Med Ther. (2018) 9:167–76. 10.2147/ahmt.s17874630464672 OmisoreAGOmisoreBAbioye-KuteyiEABelloISOlowookereSA. In-school adolescents’ weight status and blood pressure profile in south-western Nigeria: urban-rural comparison. BMC Obes. (2018) 5:2 (2018). 10.1186/s40608-018-0179-3 AbuOORajiYRAmoduOK. Risk factors for chronic kidney disease among in-school adolescents in Ibadan, Southwest, Nigeria. Sahel Med J. (2019) 22(2):64. 10.4103/smj.smj_21_18 AdeomiAAAdelusiIOAdedejiPOAwofesoAEOroleyeOOGbadegesinDL. Nutritional status and cardiometabolic health among adolescents; findings from southwestern Nigeria. BMC Nutr. (2019) 5:45. 10.1186/s40795-019-0308-532153958 Amponsem-BoatengCZhangWOppongTBOpolotGKyereEKD. A cross-sectional study of risk factors and hypertension among adolescent senior high school students. Diabetes Metab Syndr Obes Targets Ther. (2019) 12:1173–80. 10.2147/DMSO.S213552 ChungagATataCMSewani-RusikeCRNelWNkeh-ChungagBN. Ellisras longitudinal study 2017: association of hypertension with increasing levels of adiposity in 10- to 14-year-old boys and girls in the eastern cape (ELS 31). Cardiovasc J Afr. (2019) 30(5):258–61. 10.5830/CVJA-2019-01731746941 FrigatiLMahtabSNoursePRayPPerrazzoSMachemedzeT Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV. Pediatr Nephrol. (2019) 34(2):313–8. 10.1007/s00467-018-4080-630219929 LuleSANamaraBAkurutHLubyayiLNampijjaMAkelloF Blood pressure risk factors in early adolescents: results from a Ugandan birth cohort. J Hum Hypertens. (2019) 33(9):679–92. 10.1038/s41371-019-0178-y30804461 LuleSAMentzerAJNamaraBMuwenziAGNassangaBKizitoD A genome-wide association and replication study of blood pressure in Ugandan early adolescents. Mol Genet Genomic Med. (2019) 7(10):e950. 10.1002/mgg3.950 LuleSANamaraBAkurutHMuhangiLLubyayiLNampijjaM Are birthweight and postnatal weight gain in childhood associated with blood pressure in early adolescence? Results from a Ugandan birth cohort. Int J Epidemiol. (2019) 48(1):148–56. 10.1093/ije/dyy11829982658 NkwanaMRMonyekiKDMonyekiSMMakataTTMonyekiJM. Ellisras lingitudinal study 2017: the association of fat patterning with blood pressure in polokwane private school children aged five to 15 years (ELS 22). Cardiovasc J Afr. (2019) 30(3):142–5. 10.5830/CVJA-2018-05831139814 NsanyaMKKavisheBBKatendeDMoshaNHansenCNsubugaRN Prevalence of high blood pressure and associated factors among adolescents and young people in Tanzania and Uganda. J Clin Hypertens. (2019) 21(4):470–8. 10.1111/jch.13502 AbiodunOLadeleAOlu-AbiodunOAshipaT. Hypertension among adolescents in Nigeria: a retrospective study of adolescent university freshmen. Int J Adolesc Med Health. (2021) 33(5):20180287. 10.1515/ijamh-2018-0287 AzupogoFAbizariARAurinoEGelliAOsendarpSJMBrasH Malnutrition, hypertension risk, and correlates: an analysis of the 2014 Ghana demographic and health survey data for 15–19 years adolescent boys and girls. Nutrients. (2020) 12(9):1–23. 10.3390/nu12092737 KatambaGAgabaDCMigishaRNamagandaANamayanjaRTuryakiraE. Prevalence of hypertension in relation to anthropometric indices among secondary adolescents in Mbarara, Southwestern Uganda. Ital J Pediatr. (2020) 46(1):76–83. 10.1186/s13052-020-00841-432487198 MasochaVMonyekiMACzyżSH. Longitudinal relationships between changes in body composition and changes in selected metabolic risk factors (abdominal obesity and blood pressure) among South African adolescents. PeerJ. (2020) 2020(6):e9331. 10.7717/peerj.9331 MokgwathiMMwitaJC. Prevalence of hypertension and selected cardiovascular risk factors among adolescents in selected rural and urban secondary schools in Botswana. S Afr J Diabetes Vasc Dis. (2020) 7(1):23–28. 10.10520/EJC-1edab1a94e RaphaduTTVan StadenMDibakwaneWMMonyekiKD. A non-invasive investigation into the prevalence of higher than normal blood pressure, hypertension and the association between blood pressure and body weight in male and female adolescents in the Polokwane Local Municipality, Limpopo-South Africa: a cros. Children. (2020) 7(3):18. 10.3390/children703001832143272 SungwaEEKibonaSEDikaHILaisserRMGemuhayHMKabalimuTK Prevalence and factors that are associated with elevated blood pressure among primary school children in Mwanza Region, Tanzania. Pan Afr Med J. (2020) 37:283. 10.11604/pamj.2020.37.283.2111933654510 UgochukwuEFOnuboguCUOforaVCOkekeKNUjuCM. Blood pressure profiles and determinants of hypertension among public secondary school students in Nnewi, Southeast Nigeria. Eur J Med Health Sci. (2020) 2:3. 10.24018/ejmed.2020.2.3.298 UkohUUjunwaFMuonekeUManyikePOkikeCIbeB. Oscillometric blood pressure profile of adolescent secondary school students in Abakaliki metropolis. Ann Afr Med. (2020) 19(1):31–9. 10.4103/aam.aam_21_1932174613 AkinbodewaAAAdejumoAOLamidiOAAdeyemiO. Clustering of cardiometabolic risk factors among children and adolescents in a rural community in Ondo, Southwest Nigeria. J Trop Pediatr. (2021) 66(4):366–76. 10.1093/TROPEJ/FMZ075 AyoguRNBNwodoCJ. Epidemiological characteristics of hypertension, impaired fasting capillary glucose and their comorbidity: a retrospective cross-sectional population-based study of rural adolescents in Southeast Nigeria. BMJ Open. (2021) 11(5):e041481. 10.1136/bmjopen-2020-04148133952534 ChungagAEngwaGASewani-RusikeCRNkeh-ChungagBN. Effect of seasonal variation on the relationship of indoor air particulate matter with measures of obesity and blood pressure in children. J Health Pollution. (2021) 11:30. 10.5696/2156-9614-11.30.210610 du PlessisJPNienaber-RousseauCLammertynLSchutteAEPietersMKrugerHS. The relationship of circulating homocysteine with fibrinogen, blood pressure, and other cardiovascular measures in African adolescents. J Pediatr. (2021) 234:158–63.e2. 10.1016/j.jpeds.2021.03.03433775664 EngwaGLetswaloPNkeh-ChungagB. Obesity, hypertriglycaemia and endothelial dysfunction are risk factors of hypertension in South African adolescents. J Hypertens. (2021) 39(March):2021. 10.1097/01.hjh.0000746524.27921.7e LetswaloBPSchmid-ZalaudekKBrixBMatjudaENKloszFObernhumerN Cardiometabolic risk factors and early indicators of vascular dysfunction: a cross-sectional cohort study in South African adolescents. BMJ Open. (2021) 11(3):e042955. 10.1136/bmjopen-2020-04295533737426 LwabukunaWCMgondaY. Early clinical markers of metabolic syndrome among secondary school adolescents in Dar es Salaam, Tanzania. Tanzan J Health Res. (2021) 22(1):1–7. 10.4314/thrb.v22i1.3 MeerRBoatengDKlipstein-GrobuschKNorrisSAKaguraJ. Incidence and correlates of high blood pressure from childhood to adulthood: the birth to twenty study. J Hypertens. (2022) 40(2):274–82. 10.1097/HJH.000000000000300434475345 Nganou-GnindjioCNEssamaDBNkeckJRTchebegnaPYTchatchouangKMTankeuA Prevalence and factors associated with hypertension among school children and adolescents in urban and semi-urban areas in Cameroon. J Clin Hypertens. (2021) 23(8):1490–7. 10.1111/jch.14309 SekokotlaAMIputoJESewani-RusikeCRMalemaIMAdeniyiOVGoonDT Serum magnesium and high-sensitive c-reactive proteins in hypertensive, obese female school learners. West Indian Med J. (2021) 69(1):32–7. 10.7727/wimj.2015.292 ShokunbiOSUkangwaNA. Relationship of blood pressure status, dietary factors and serum electrolytes of in-school adolescents in Ilishan-Remo, Ogun State, Nigeria. Afr Health Sci. (2021) 21(4):1754–63. 10.4314/ahs.v21i4.3235283970 NHLBI. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. (2004) 114(2):555–76. 10.1542/peds.114.2.S2.55515286277 ThurstonSWBovetPMyersGJDavidsonPWGeorgerLAShamlayeC Does prenatal methylmercury exposure from fish consumption affect blood pressure in childhood? NeuroToxicology. (2007) 28(5):924–30. 10.1016/j.neuro.2007.06.00217659343 KavisheBBiraroSBaisleyKVanobberghenFKapigaSMunderiP High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in northwestern Tanzania and Southern Uganda. BMC Med. (2015) 13:126–47. 10.1186/s12916-015-0357-926021319 PeckRGreenEMtabajiJMajingeCSmartLDownsJ Hypertension related diseases as a common cause of hospital mortality in Tanzania. A 3 year prospective study. J Hypertens. (2014) 31(9):1806–11. 10.1097/HJH.0b013e328362bad7.HYPERTENSION-RELATED PeckRBaisleyKKavisheBWereJMghambaJSmeethL Decreased renal function and associated factors in cities, towns and rural areas of Tanzania: a community-based population survey. Trop Med Int Health. (2016) 21(3):393–404. 10.1111/tmi.1265126644310 MyersMGMcInnisNHFodorGJLeenenFHH. Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens. (2008) 21(3):280–3. 10.1038/ajh.2007.5418219304 StergiouGSBoubouchairopoulouNKolliasA. Accuracy of automated blood pressure measurement in children evidence, issues, and perspectives. Hypertension. (2017) 69(6):1000–6. 10.1161/HYPERTENSIONAHA.116.0855328438903 SteinbergerJDanielsSRHagbergNIsasiRCKelllyASLloyd-JonesD Cardiovascular health promotion in children: challenges and opportunities for 2020 and beyond. Circulation. (2016) 134:e236–55. 10.1161/CIR.000000000000044127515136 WoronieckiRPKahnauthAPanesarLESupe-MarkovinaK. Left ventricular hypertrophy in pediatric hypertension: a mini review. Front Pediatr. (2017) 5(May):1–7. 10.3389/fped.2017.0010128180126